Core Viewpoint - MindBio Therapeutics Corp. is advancing its AI-driven technology for drug and alcohol intoxication detection, aiming to disrupt traditional testing methods in the mining industry, particularly in South America [1][6]. Group 1: Technology and Applications - The company has developed a world-first AI prediction tool that analyzes voice to detect intoxication from substances like alcohol, hallucinogens, and plans to expand to other drugs [1][5]. - The technology is being positioned as an enterprise solution for the mining industry, where it can serve as a first-line screening method for multiple substances at entry points [2][3]. - Current drug and alcohol testing methods in the mining sector are slow, expensive, and invasive, often requiring bodily fluid samples, which the company's technology aims to replace with a non-invasive voice analysis [3][5]. Group 2: Market Opportunity and Industry Context - In Chile, over 75% of mining workers consume alcohol, with more than 40% identified as problem drinkers, and 9% using drugs, highlighting a significant market need for effective screening solutions [4]. - Internationally, 20-25% of occupational accidents are linked to substance use, indicating a substantial opportunity for MindBio's technology to reduce workplace incidents and associated costs [4]. - The CEO expressed optimism about the commercial interest from the mining industry, viewing it as a massive opportunity to transform drug and alcohol testing processes globally [6][7].